首页> 外国专利> METHOD AND ROUTE(S) OF ADMINISTRATION FOR THE PREPARATION AND/OR PREPARATION OF A PHARMACEUTICAL SUBSTANCE APPROVED WITH A 4-OMEGA (CUMARINE-7-YLOXY) ALKYL PIPERAZINE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION FOR THERAPEUTICAL USE

METHOD AND ROUTE(S) OF ADMINISTRATION FOR THE PREPARATION AND/OR PREPARATION OF A PHARMACEUTICAL SUBSTANCE APPROVED WITH A 4-OMEGA (CUMARINE-7-YLOXY) ALKYL PIPERAZINE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION FOR THERAPEUTICAL USE

机译:制备和/或制备经4-OMEGAMIN(CUMARINE-7-YOHXY)烷基哌嗪药用产品批准的药物的管理方法和路线以及用于治疗用途的管理路线

摘要

1335946 Coumarin-7-yloxyalkyl-piperazine derivatives BOEHRINGER MANNHEIM GmbH 11 May 1972 [14 May 1971] 22070/72 Heading C2C Novel compounds of the Formula (I) wherein R 1 is a hydrogen atom or a C 1-5 alkyl radical, R 2 is a C 1-5 alkyl radical, R 3 is an unsubstituted or substituted phenyl or benzyl radical, the substituents, when present, being halogen atoms or C 1-5 alkyl or C 1-5 alkoxy radicals, and n is 1, 2 or 3; and the pharmacologically compatible salts thereof, may be obtained by (a) condensing a compound of the Formula (II) in which X is a halogen atom, with a 7-hydroxy- 3 - R 1 - 4 - R 2 - substituted - coumarin, (b) condensation of a compound of the Formula (IV) with an R 3 -substituted-piperazine, (c) condensation of a compound of Formula (I), in which R 3 is H, with a compound of the formula X.R 3 , in which R 3 is an unsubstituted or substituted benzyl radical; or (d) condensation of a compound of the Formula (VII) with an amine of formula H 2 N-R 3 , and thereafter, if desired, converting the products into their physiologically compatible salts. Pharmaceutical compositions having antiinflammatory and anti-allergic action comprise at least one compound of the Formula (I) in admixture with a solid or liquid pharmaceutical diluent or carrier, for example in the form of tablets or dragees or suspended or dissolved in water or an oil.
机译:1335946香豆素-7-烷氧基烷基哌嗪衍生物BOEHRINGER MANNHEIM GmbH 1972年5月11日[1971年5月14日]标题C2C其中R 1为氢原子或C 1-5烷基的式(I)的新化合物,R 2为C 1-5烷基,R 3为未取代或取代的苯基或苄基,当存在时,取代基为卤素原子或C 1-5烷基或C 1-5烷氧基,n为1, 2或3;及其药理学上相容的盐可通过(a)使X为卤原子的式(II)化合物与7-羟基-3-R 1 -R 4 -R 2-取代的香豆素缩合而获得。 ,(b)式(IV)的化合物与R 3-取代的哌嗪的缩合,(c)R 3为H的式(I)的化合物与式XR的化合物的缩合。 3,其中R 3是未取代或取代的苄基; (d)将式(VII)的化合物与式H 2 N-R 3的胺缩合,然后,如果需要,将产物转化为其生理上相容的盐。具有抗炎和抗过敏作用的药物组合物包含至少一种式(I)的化合物与固体或液体药物稀释剂或载体的混合物,例如片剂或糖衣丸的形式或悬浮或溶解于水或油中。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号